GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Ending Cash Position

Takara Bio (TSE:4974) Ending Cash Position : 円33,171 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Ending Cash Position?

Takara Bio's Ending Cash Position for the quarter that ended in Mar. 2024 was 円33,171 Mil.

Takara Bio's quarterly Ending Cash Position declined from Sep. 2023 (円36,065 Mil) to Dec. 2023 (円33,761 Mil) and declined from Dec. 2023 (円33,761 Mil) to Mar. 2024 (円33,171 Mil).

Takara Bio's annual Ending Cash Position increased from Mar. 2022 (円22,160 Mil) to Mar. 2023 (円49,058 Mil) but then declined from Mar. 2023 (円49,058 Mil) to Mar. 2024 (円33,171 Mil).

Takara Bio Ending Cash Position Historical Data

The historical data trend for Takara Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Ending Cash Position Chart

Takara Bio Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,462.00 23,308.00 22,160.00 49,058.00 33,171.00

Takara Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49,058.00 43,818.00 36,065.00 33,761.00 33,171.00

Takara Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Takara Bio's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=49058+-15887
=33,171

Takara Bio's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=33762+-591
=33,171

Takara Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Takara Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Ending Cash Position
Comparable Companies
TSE:4587 TSE:4565 TSE:2160 TSE:4599 TSE:4880 TSE:4592 TSE:7096 TSE:7774 TSE:4978 TSE:4893 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
TF2:Germany
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Website
http://www.takara-bio.co.jp
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines